Literature DB >> 10881485

Sepsis and the systemic inflammatory response syndrome.

R L Paterson1, N R Webster.   

Abstract

Sepsis and the systemic inflammatory response syndrome are common and represent a major factor in morbidity and mortality in intensive care units and the critically ill. The pathogenesis of these syndromes is becoming increasingly understood and it is hoped that this will result in improved outcome. However, novel treatments have so far failed to live up to the expectations following extensive and promising in vitro and in vivo animal studies. The aim of this review is to detail the currently used definitions of systemic inflammatory response syndrome, sepsis and septic shock and to present an overview of our current understanding of the pathophysiology which underline these conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881485

Source DB:  PubMed          Journal:  J R Coll Surg Edinb        ISSN: 0035-8835


  14 in total

1.  Relationship between cytokine mRNA expression and organ damage following cecal ligation and puncture.

Authors:  Rong-Qian Wu; Ying-Xin Xu; Xu-Hua Song; Li-Jun Chen; Xian-Jun Meng
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Expression of CD11c and EMR2 on neutrophils: potential diagnostic biomarkers for sepsis and systemic inflammation.

Authors:  S M Lewis; D F Treacher; J Edgeworth; G Mahalingam; C S Brown; T A Mare; M Stacey; R Beale; K A Brown
Journal:  Clin Exp Immunol       Date:  2015-09-22       Impact factor: 4.330

Review 3.  [Role of adrenomedullin in the pathogenesis and treatment of cardiovascular dysfunctions and sepsis].

Authors:  M Westphal; J Sander; H Van Aken; C Ertmer; H D Stubbe; M Booke
Journal:  Anaesthesist       Date:  2006-02       Impact factor: 1.041

4.  Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis.

Authors:  Gang Zhou; George Kamenos; Suresh Pendem; John X Wilson; Feng Wu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-23       Impact factor: 3.619

5.  Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles.

Authors:  Vellaisamy Selvaraj; Niraj Nepal; Steven Rogers; Nandini D P K Manne; Ravikumar Arvapalli; Kevin M Rice; Shinichi Asano; Erin Fankhanel; Jane J Ma; Tolou Shokuhfar; Mani Maheshwari; Eric R Blough
Journal:  Biomaterials       Date:  2015-05-15       Impact factor: 12.479

6.  Biofilm detection and the clinical significance of Staphylococcus epidermidis isolates.

Authors:  F Růzicka; V Holá; M Votava; R Tejkalová; R Horvát; M Heroldová; V Woznicová
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

7.  IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality.

Authors:  Hong Zhang; Patrick Neuhöfer; Liang Song; Björn Rabe; Marina Lesina; Magdalena U Kurkowski; Matthias Treiber; Thomas Wartmann; Sara Regnér; Henrik Thorlacius; Dieter Saur; Gregor Weirich; Akihiko Yoshimura; Walter Halangk; Joseph P Mizgerd; Roland M Schmid; Stefan Rose-John; Hana Algül
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

8.  Protective Effects of Nobiletin Against Endotoxic Shock in Mice Through Inhibiting TNF-α, IL-6, and HMGB1 and Regulating NF-κB Pathway.

Authors:  Weifeng Li; Xiumei Wang; Xiaofeng Niu; Hailin Zhang; Zehong He; Yu Wang; Wenbing Zhi; Fang Liu
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

9.  Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock.

Authors:  Adam Linder; Per Åkesson; Malin Inghammar; Carl-Johan Treutiger; Anna Linnér; Jonas Sundén-Cullberg
Journal:  Crit Care       Date:  2012-05-21       Impact factor: 9.097

10.  Importance of biofilm in Candida parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric method.

Authors:  F Růzicka; V Holá; M Votava; R Tejkalová
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.